Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
69.6M
-
Shares change
-
-2.1M
-
Total reported value, excl. options
-
$763M
-
Value change
-
-$11M
-
Put/Call ratio
-
3.6
-
Number of buys
-
73
-
Number of sells
-
-69
-
Price
-
$10.96
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q3 2024
176 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q3 2024.
Replimune Group, Inc. - COMMON STOCK (REPL) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69.6M shares
of 78.4M outstanding shares and own 88.77% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (11M shares), PRICE T ROWE ASSOCIATES INC /MD/ (9.88M shares), BlackRock, Inc. (5.47M shares), FCPM III SERVICES B.V. (4.87M shares), Redmile Group, LLC (4.78M shares), VANGUARD GROUP INC (3.47M shares), BRAIDWELL LP (3.07M shares), Omega Fund Management, LLC (2.46M shares), STATE STREET CORP (2.34M shares), and MORGAN STANLEY (1.69M shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.